Search Results - "WIJNEN, Petal A"

Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis by de Kleijn, Willemien P.E, De Vries, Jolanda, Wijnen, Petal A.H.M, Drent, Marjolein

“…Summary Objective The usefulness of any questionnaire in clinical management and research trials depends on its ability to indicate a likelihood of treatment…”
Get full text

Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers by Jessurun, Naomi T, Wijnen, Petal A, Bast, Aalt, van Puijenbroek, Eugène P, Bekers, Otto, Drent, Marjolein

“…Drugs are serious but underestimated causative agents of interstitial lung disease (ILD). Both cytotoxic and immune mechanisms may be involved in drug-induced…”
Get full text

Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis by de Brouwer, Bart, Drent, Marjolein, van den Ouweland, Jody M W, Wijnen, Petal A, van Moorsel, Coline H M, Bekers, Otto, Grutters, Jan C, White, Eric S, Janssen, Rob

“…Although chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) seem to be opposite entities from a clinical perspective, common…”
Get full text

Therapeutic approach of hepatic sarcoidosis by Cremers, Johanna P, Drent, Marjolein, Baughman, Robert P, Wijnen, Petal A, Koek, Ger H

“…PURPOSE OF REVIEWSurveillance of hepatic involvement in sarcoidosis has not been standardized. Therefore, management of hepatic involvement is a clinical…”
Get full text

Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression? by Wijnen, Petal A, Voorter, Christina E, Nelemans, Patty J, Verschakelen, Johny A, Bekers, Otto, Drent, Marjolein

“…Abstract The aims of this study were to assess the association of BTNL2 G16071 A with the course of pulmonary sarcoidosis and to verify the association with…”
Get full text

Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease by Drent, Marjolein, Wijnen, Petal A., Jessurun, Naomi T., Harmsze, Ankie M., Bekers, Otto, Bast, Aalt

“…Background Pulmonary toxicity has been associated with drug use. This is often not recognized in clinical practice, and underestimated. Objective We aimed to…”
Get full text

Drug-induced comorbidities in patients with sarcoidosis by Drent, Marjolein, Jessurun, Naomi T., Wijnen, Petal A., Bekers, Otto, Bast, Aalt

“…Purpose of review Sarcoidosis is a chronic multisystemic inflammatory disease of unknown aetiology with a wide range of highly variable clinical manifestations…”
Get full text

Association of the TNF-α G-308A polymorphism with TNF-inhibitor response in sarcoidosis by WIJNEN, Petal A, CREMERS, Johanna P, NELEMANS, Patty J, ERCKENS, Roel J, HOITSMA, Elske, JANSEN, Tim L, BEKERS, Otto, DRENT, Marjolein

“…Responsiveness to tumour necrosis factor (TNF) inhibitors has been associated with the TNF-α G-308A polymorphism in rheumatoid arthritis. The aim of this study…”
Get full text

Role of Cytochrome P450 Polymorphisms in the Development of Pulmonary Drug Toxicity: A Case-Control Study in the Netherlands by Wijnen, Petal A. H. M., Drent, Marjolein, Nelemans, Patty J., Kuijpers, Petra M. J. C., Koek, Ger H., Neef, Cees, Haenen, Guido R. M. M., Bekers, Otto

“…Background: Drug-induced pulmonary toxicity is a serious and expanding problem with often unknown aetiology. Many drugs are metabolized by cytochrome P450…”
Get full text

Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients by Olie, Renske H, Hensgens, Rachelle R K, Wijnen, Petal A H M, Veenstra, Leo F, de Greef, Bianca T A, Vries, Minka J A, van der Meijden, Paola E J, Ten Berg, Jurriën M, Ten Cate, Hugo, Bekers, Otto, Henskens, Yvonne M C

“…On-treatment platelet reactivity in clopidogrel-treated patients can be measured with several platelet function tests (PFTs). However, the agreement between…”
Get full text

Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity by Jessurun, Naomi T., Drent, Marjolein, Wijnen, Petal A., Harmsze, Ankie M., van Puijenbroek, Eugène P., Bekers, Otto, Bast, Aalt

“…Introduction Simvastatin has previously been associated with drug-induced interstitial lung disease. In this retrospective observational study, cases with…”
Get full text

Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects by Jessurun, Naomi T, Drent, Marjolein, van Puijenbroek, Eugène P, Bekers, Otto, Wijnen, Petal A, Bast, Aalt

“…PURPOSE OF REVIEWThe diagnosis of drug-induced interstitial lung disease (DI-ILD) is challenging and mainly made by exclusion of other possible causes…”
Get full text

Drug-induced interstitial lung disease: role of pharmacogenetics in predicting cytotoxic mechanisms and risks of side effects by Jessurun, Naomi T, Drent, Marjolein, van Puijenbroek, Eugène P, Bekers, Otto, Wijnen, Petal A, Bast, Aalt

“…The diagnosis of drug-induced interstitial lung disease (DI-ILD) is challenging and mainly made by exclusion of other possible causes. Toxicity can occur as a…”
Get full text

Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment by Elfferich, Marjon D, Nelemans, Patty J, Ponds, Rudolf W, De Vries, Jolanda, Wijnen, Petal A, Drent, Marjolein

“…Cognitive symptoms, such as concentration problems, are frequently recorded by sarcoidosis patients. The aim of this study was to assess the prevalence of…”
Get more information

Everyday cognitive failure in patients suffering from neurosarcoidosis by Voortman, Mareye, De Vries, Jolanda, Hendriks, Celine M R, Elfferich, Marjon D P, Wijnen, Petal A H M, Drent, Marjolein

“…Cognitive failure is associated with memory and concentration problems. Previously, a prevalence of one third was found in a general sarcoidosis population…”
Get full text

F-18 FDG PET/CT for Detecting Bone and Bone Marrow Involvement in Sarcoidosis Patients by Mostard, Rémy L, Prompers, Léonne, Weijers, Rene E, van Kroonenburgh, Marinus J, Wijnen, Petal A, Geusens, Piet P, Drent, Marjolein

“…BACKGROUND:The prevalence of bone involvement in sarcoidosis has been estimated to be 3% to 5%, mostly affecting the phalanges. The aim of this study was to…”
Get full text

Acute eosinophilic pneumonia associated with glyphosate-surfactant exposure by De Raadt, Wanda M, Wijnen, Petal A, Bast, Aalt, Bekers, Otto, Drent, Marjolein

“…We report a case of a female patient who developed acute eosinophilic pneumonia (AEP) after recent onset of smoking and exposure to glyphosate-surfactant.The…”
Get full text

Diffuse Alveolar Hemorrhage in Coumarin Users: A Fibrosing Interstitial Pneumonia Trigger? by Wijnen, Petal A., Verschakelen, Johny A., Bast, Aalt, Bekers, Otto, Drent, Marjolein

“…Background Fibrosing interstitial pneumonias (IPs) include idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP). It has been…”
Get full text

Relationship between drug-induced interstitial lung diseases and cytochrome P450 polymorphisms by Wijnen, Petal AHM, Bekers, Otto, Drent, Marjolein

“…PURPOSE OF REVIEWInterstitial lung disease and especially drug-induced interstitial lung disease can occur as a cause of drug(s) or drug–drug interactions. In…”
Get full text

Development of Cocaine-Induced Interstitial Lung Damage in Two CYP2C and VKORC1 Variant Allele Carriers by Wijnen, Petal A.H.M., Bekers, Otto, Drent, Marjolein

“…Background: Often, the connection between drug use and the development of related inflammatory damage or idiosyncratic toxicities is hard to recognize and…”
Get full text